Insilico Medicine, Biopharmaceuticals Strike: AI Drug Deal Heads Toward $2.5B
Insilico Medicine and SK Biopharmaceuticals unveiled a milestone collaboration worth up to $2.5 billion to develop ne...
Target discretionary areas first, compare frequent bills, and negotiate rates to reduce outflows while maintaining needs.
14,378 articlesInsilico Medicine and SK Biopharmaceuticals unveiled a milestone collaboration worth up to $2.5 billion to develop ne...
Imagine you have $5,000 to invest today. Rather than chasing the latest space stock sensation, you might choose a tri...
Choosing between broad energy exposure and high-yield pipelines requires weighing costs, income, and risk. This guide...
Qualcomm rolls out a five year plan to compete with Nvidia in AI data center chips, aiming for multi billion dollar A...
Meta Platforms has shown business momentum even as its stock traded lower. This guide weighs the case to buy, sell, o...
A new wave of data shows AI adoption growing in everyday money management, even as academics debate how fast the shif...
When a company's chief financial officer sells a sizable stake, investors want to know what it means. This deep dive ...
Investors are watching whispers about Apple and Intel teaming up. This article breaks down what that could mean for s...
Base edges Ethereum in June's adjusted stablecoin volume, signaling a shift in crypto payments rails and spotlighting...
The AI IPO wave is heating up, and Anthropic sits at the center. This guide explains how early backers could see wind...
A sharp look at how Rivian Automotive and Tesla earn money, where their revenue comes from, and what the trends mean ...
GhostSwap launches a no-onboarding swap experience that lets users exchange 1,600+ tokens in minutes, without email, ...